Connect with us

Politics

Trump Grants Clemency To Marijuana Prisoners On Last Day In Office

Published

on

As one of his final acts in the White House, President Trump on Wednesday announced that he has granted clemency to dozens more people with marijuana and drug convictions.

The latest batch of pardons and commutations is the product of a push from advocates, celebrities and even some Republican lawmakers, who coordinated with White House staff over the course of Trump’s administration.

In a letter sent to the president in November, the coalition noted the president’s comments supporting bipartisan legislation to protect state cannabis programs from federal intervention and argued that congressional gridlock meant that those most harmed under federal prohibition would go without relief unless executive action was taken.

They also attached a list of people incarcerated in federal prison who they felt were most deserving of clemency—an addendum that was requested by the office of Trump senior adviser and son-in-law Jared Kushner. Now the White House has granted relief to several of those names.

One of the people on that list, Craig Cesal, was granted clemency for his cannabis conviction that landed him a life sentence.

“It feels like a new life, even though I don’t even know the terms yet,” Cesal, who received a call about the news on Tuesday evening from Ivanka Trump, the president’s daughter, told Marijuana Moment. “Just to know that I won’t have to go back to the prison after COVID abates is a huge relief.”

Cesal was released to home confinement in June.

“Many, many marijuana activists have worked for years to make this happen for me, with the Last Prisoner Project helping recently with my reintegration into society,” he said. “My release and my clemency is due solely to the efforts of many marijuana activist groups, and I thank each and every one of them.”

Another recipient of the presidential action is Michael Pelletier, who has served 14 years of a life sentence over a federal marijuana conviction. He’s been a paraplegic since age 11 and is currently 64.

Weldon Angelos, an activist who received a presidential pardon for a federal marijuana conviction last month and has been involved in the White House talks about further clemency, told Marijuana Moment that he’s been encouraged by the progress that advocates have been able to make.

However, one person he fought especially hard for—Luke Scarmazzo, who was sentenced to 22 years in federal prison for operating a state-legal medical cannabis business in California—did not make Wednesday’s clemency list. Angelos said it’s possible he was passed up at the last minute, or that he will be granted relief in another round of clemency on Wednesday.

Although Trump would need to sign any grant of relief prior to the end of his term at noon, there is no requirement in federal law that it be publicly announced by that time in order to take effect.

“He was following state law—and they used his case to send the message,” Angelos said, of Scarmazzo. “He got charged under a kingpin statute, as though he was a cartel member, rather than providing medicinal cannabis for people that needed it.”

In all, 12 people with marijuana-related convictions were included in the latest round of clemency actions, and more than two dozen others with other drug offenses on their records were also granted pardons or commutations.

Of course, while Trump campaigned during his reelection bid as the criminal justice reform candidate, certain administrative actions have raised questions about that—such as the revival of federal executions for people on death row. He hasn’t done anything to proactively promote marijuana policy reform either, and has taken a number of hostile budget actions related to cannabis while also hiring several key officials who hold anti-legalization views.

Asked what message he felt resonated with the White House when it came to presidential clemency for nonviolent drug offenders, Angelos said he thinks Trump “is not a typical politician, and so he doesn’t make the same political calculations as other presidents.”

“I think Trump was also very skeptical of the government,” he said, as well as the criminal proceedings that land people in prison for lengthy sentences over minor crimes.

As with his last batch of pardons and commutations, it’s possible that these particular actions for people with drug-related convictions will be overshadowed by the slew of other clemency decisions that are rolling out, such as one for former Trump advisor Steve Bannon.

And at the same time that Angelos was pardoned last month, Trump gave clemency to allies and controversial figures such as Roger Stone, Paul Manafort, former Republican members of Congress and the team of four private military contractors convicted of killing 17 Iraqi civilians in the 2007 Nisour Square massacre.

But advocates—including Angelos and Alice Johnson, who also received a presidential commutation in 2018—are going to take their wins where they can get them.

Wednesday was “a day to honor mercy and justice, a day to celebrate the second chance given to many deserving individuals, and the families and communities who have been reunited with their loved ones,” Johnson said in a press release.

“While we celebrate today, let us not forget we still have laws in place that put nonviolent people in prison for life and there remain thousands behind bars today, who have paid their debt to society and who deserve a second chance to return home,” she added. “Today is just more fuel for the fire in my heart to continue to fight for those who have no voice.”

The 2020 letter that informed some of the new cannabis-related clemency actions was supported by Republican state lawmakers from Kansas, Maine and Missouri, as well as a former U.S. attorney, actor Danny Trejo, the New Haven, Missouri police chief and former New Mexico governor and former presidential candidate Gary Johnson. They were joined by representatives of groups like #cut50, Marijuana Policy Project and Law Enforcement Action Partnership.

Activists are cautiously optimistic that between the new Democratic Senate and the incoming presidential administration, this trend of drug war relief will continue. Despite a history of championing punitive anti-drug legislation during his time as a senator, President-elect Joe Biden has called those efforts a mistake and now backs some modest marijuana reforms.

Read the full list of new marijuana-related pardons and commutations below:

Ferrell Damon Scott – President Trump commuted the sentence of Ferrell Damon Scott. This commutation is supported by former Acting United States Attorney Sam Sheldon, who prosecuted his case and wrote that he “… strongly does not believe that [Mr. Scott] deserves a mandatory life sentence.” Ms. Alice Johnson, the CAN-DO Foundation, and numerous others also support clemency for Mr. Scott. Mr. Scott has served nearly 9 years of a life imprisonment sentence for possession with intent to distribute marijuana. Under today’s sentencing guidelines, it is likely that Mr. Scott would not have received such a harsh sentence.

John Knock – President Trump commuted the sentence of John Knock. This commutation is supported by his family. Mr. Knock is a 73 year-old man, a first-time, non-violent marijuana only offender, who has served 24 years of a life sentence. Mr. Knock has an exemplary prison history, during which he completed college accounting classes and has had zero incident reports.

Anthony DeJohn – President Trump commuted the sentence of Anthony DeJohn. Mr. DeJohn has served more than 13 years of a life sentence for conspiracy to distribute marijuana. Mr. DeJohn has maintained a clear disciplinary record and has been recognized for his outstanding work ethic while incarcerated. Mr. DeJohn has employment and housing available to him upon release.

Corvain Cooper – President Trump commuted the sentence of Mr. Corvain Cooper. Mr. Cooper is a 41 year-old father of two girls who has served more than 7 years of a life sentence for his non-violent participation in a conspiracy to distribute marijuana.

Way Quoe Long – President Trump commuted the sentence of Way Quoe Long. Mr. Long is a 58 year-old who has served nearly half of a 50-year sentence for a non-violent conviction for conspiracy to manufacture and distribute marijuana. Mr. Long has spent his incarceration striving to better himself through English proficiency classes and by obtaining his GED. Upon release, Mr. Long will reunite with his family and will be strongly supported as he integrates back into the community.

Michael Pelletier – President Trump commuted the sentence of Michael Pelletier. Mr. Pelletier is a 64 year-old who has served 12 years of a 30 year sentence for conspiracy to distribute marijuana. Mr. Pelletier has maintained a clear disciplinary record, has thrived as an artist working with oil paints on canvas, and has taken several courses to perfect his skill while incarcerated. Upon his release, Mr. Pelletier will have a meaningful place of employment and housing with his brother.

Craig Cesal – President Trump commuted the sentence of Craig Cesal. Mr. Cesal is a father of two, one of whom unfortunately passed away while he was serving his life sentence for conspiracy to distribute marijuana. Mr. Cesal has had an exemplary disciplinary record and has become a paralegal assistant and a Eucharistic Minister in the Catholic Church to assist and guide other prisoners. Upon his release, Mr. Cesal looks forward to reintegrating back into society and to contributing to his community while living with his daughter with whom he has remained close. Mr. Cesal hopes to be a part of her upcoming wedding.

Brian Simmons – President Trump commuted the sentence of Brian Simmons. Mr. Simmons has served 5 years of a 15 year sentence for a non-violent conspiracy to manufacture and distribute marijuana. Mr. Simmons has had an exemplary prison record and upon release will have strong support from his fiancée and his community.

James Romans – President Trump commuted the sentence of James Romans. Mr. Romans is a father and a grandfather who received a life sentence without parole for his involvement in a conspiracy to distribute marijuana. Mr. Romans has had an exemplary disciplinary record for the more than 10 years he has served, and has completed a long list of courses. He has already secured job opportunities that will help him successfully re-enter society.

Jonathon Braun – President Trump commuted the sentence of Jonathan Braun. Mr. Braun has served 5 years of a 10-year sentence for conspiracy to import marijuana and to commit money laundering. Upon his release, Mr. Braun will seek employment to support his wife and children.

Noah Kleinman – President Trump commuted the sentence of Noah Kleinman. Mr. Kleinman is a 45-year old father of two children. The mother of his children unfortunately passed away during Mr. Kleinman’s incarceration. Mr. Kleinman has served 6 years of a nearly 20 year sentence for a non-violent crime to distribute marijuana. Mr. Kleinman has had an exemplary prison history and has worked to remain close to his children and his father. Upon release, he looks forward to living with his father, working for the family business, and caring for his children.

Lynn Barney – President Trump granted a full pardon to Lynn Barney. This pardon is supported by Senator Mike Lee, as well as numerous notable members of the Utah business community. Mr. Barney was sentenced to 35 months in prison for possessing a firearm as a previously convicted felon, after having previously been convicted for distributing a small amount of marijuana. Since his release from prison, Mr. Barney has been a model citizen and has devoted himself to his work and children. He is described by his employer as an exceedingly hard worker and a role model to other employees.

Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Sacramento-based senior editor. His work has also appeared in High Times, VICE and attn.

Politics

Top IRS Official Says Marijuana Banking Reform Would Help Feds ‘Get Paid’

Published

on

The Internal Revenue Service (IRS) would like to get paid—and it’d help if the marijuana industry had access to banks like companies in other legal markets, an official with the federal department said. She also talked about unique issues related to federal tax deductions for cannabis businesses.

At an event hosted by UCLA’s Annual Tax Controversy Institute on Thursday, IRS’s Cassidy Collins talked about the “special type of collection challenge” that the agency faces when it comes to working with cannabis businesses while the product remains federally illegal.

While IRS isn’t taking a stand on federal marijuana policy, Collins said that the status quo leaves many cannabis businesses operating on a cash-only basis, creating complications for the agency, in part by making it harder for banks to “pay us.”

“The reason why [the marijuana industry is] cash intensive is twofold,” she said. “Number one, a lot of customers don’t want a paper trail showing that they’re buying marijuana, and number two, the hesitancy of banks to allow marijuana businesses to even bank with them.”

Of course, the reason why many financial institutions remain hesitant to take on cannabis companies as clients is because the plant is a strictly controlled substance under federal law.

“There’s been a number of legislative bills that have been introduced—and I am definitely not expressing any opinion personally or on behalf of the IRS about any pending or proposed legislation,” Collins, who is a senior counsel in the IRS Office of Chief Counsel, said. “But it is interesting to note that, if the law changed so that the marijuana businesses could have banks, that would make the IRS’s job to collect [taxes] a lot easier. As part of collection, we want the money. That’s our end goal there.”

A major part of what makes cannabis businesses unique is that they don’t qualify for traditional tax credits under an IRS code known as 280E. That policy “prohibits them from claiming deductions for business expenses because they’re technically being involved in drug trafficking,” Collins explained at the event, from which small excerpts of her comments were reported by Bloomberg.

There are some options available to lessen the burden on marijuana firms, however. At the end of the day, “IRS will work with marijuana companies because, again, we want to get paid,” Collins said.

One of the ways the agency works with marijuana business operators is to have them visit designated IRS “tax assistance centers” that accept cash payments in excess of $50,000. But the official warned businesses to “be prepared to be there for a little while” as the center checks—and double checks—the amount of cash being submitted.

“Revenue officers will assist the marijuana companies in paying us,” she said.

IRS officials could also help cannabis firms by having officials accompany them “to the bank in order to try to help the taxpayer secure a cashier’s payment to pay the IRS, as well as using money orders,” she said, adding that “our revenue officers are are wanting to work with the marijuana companies to help assist them to pay us.”

“When the revenue officers are there in person with the taxpayer, that could potentially help increase the likelihood that the bank will cooperate and help the taxpayer transition into a cashier’s check,” she continued. “And that has been a trend since this first became legal [at the state level], that more and more banks are allowing cannabis companies to bank with them.”

In a report published earlier this year, congressional researchers examined tax policies and restrictions for the marijuana industry—and how those could change if any number of federal reform bills are enacted.

IRS, for its part, said last month that it expects the cannabis market to continue to grow, and it offered some tips to businesses on staying compliant with taxes while the plant remains federally prohibited.

As it stands, banks and credit unions are operating under 2014 guidance from the Financial Crimes Enforcement Network (FinCEN) that lays out reporting requirements for those that choose to service the marijuana industry.

Leaders in both chambers of Congress are working on legalization bills to end federal marijuana prohibition. But stakeholders are hopeful that, in the interim, legislators will enact modest marijuana banking reform. Legislation to protect financial institutions from being penalized for working with cannabis businesses passed the House for the fifth time last month.

Rodney Hood, a board member of the National Credit Union Administration, wrote in a Marijuana Moment op-ed this month that legalization is an inevitability—and it makes the most sense for government agencies to get ahead of the policy change to resolve banking complications.

IRS separately hosted a forum in August dedicated to tax policy for marijuana businesses and cryptocurrency.

Earlier this year, IRS Commissioner Charles Rettig told Congress that the agency would “prefer” for state-legal marijuana businesses to be able to pay taxes electronically, as the current largely cash-based system under federal cannabis prohibition is onerous and presents risks to workers.

Former Treasury Secretary Steven Mnuchin said in 2019 that he’d like to see Congress approve legislation resolving the cannabis banking issue and he pointed to the fact that IRS has had to build “cash rooms” to deposit taxes from those businesses as an example of the problem.

IRS released updated guidance on tax policy for the marijuana industry last year, including instructions on how cannabis businesses that don’t have access to bank accounts can pay their tax bills using large amounts of cash.

The update appears to be responsive to a Treasury Department internal watchdog report that was released earlier in the year. The department’s inspector general for tax administration had criticized IRS for failing to adequately advise taxpayers in the marijuana industry about compliance with federal tax laws. And it directed the agency to “develop and publicize guidance specific to the marijuana industry.”

Luxembourg Set To Become First European Country To Legalize Marijuana Following Government Recommendation

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Luxembourg Set To Become First European Country To Legalize Marijuana Following Government Recommendation

Published

on

Luxembourg is poised to become the first European country to legalize marijuana, with key government agencies putting forward a plan to allow the possession and cultivation of cannabis for personal use.

The ministers of justice and homeland security on Friday unveiled the proposal, which will still require a vote in the Parliament but is expected to pass. It’s part of a broader package of reform measures the agencies are recommending.

Under the marijuana measure, adults 18 and older could grow up to four plants. However, under the non-commercial model that is being proposed, possessing more than three grams in public would still be a civil offense, carrying a fine of €25-500 ($29-581). Currently, the maximum fine for possession is €2,500 ($2,908).

In terms of access, adults would be able to buy and trade cannabis seeds for their home garden.

Justice Minister Sam Tamson said the government felt it “had to act” and characterized the home cultivation policy change as a first step, The Guardian reported.

“The idea is that a consumer is not in an illegal situation if he consumes cannabis and that we don’t support the whole illegal chain from production to transportation to selling where there is a lot of misery attached,” he said. “We want to do everything we can to get more and more away from the illegal black market.”

While limited in scope, the reform would make Luxembourg the first country in Europe to legalize the production and possession of marijuana for recreational use. Cannabis has been widely decriminalized in certain countries in the continent, but it has remained criminalized by statute.

Government sources in Luxembourg told The Guardian that plans are in the works to develop a program where the state regulates the production and distribution of marijuana. Tamson said they are working to resolve “international constraints” before taking that step, however, referring to United Nations treaty obligations that multiple U.S. states and other countries like Canada and Uruguay have openly flouted.

For now, the country is focusing on legalization within a home setting. Parliament is expected to vote on the proposal in early 2022, and the ruling parties are friendly to the reform.

This has been a long time coming, as a coalition of major parties of Luxembourg agreed in 2018 to enact legislation allowing “the exemption from punishment or even legalization” of cannabis.

Meanwhile in the U.S., congressional lawmakers are working to advance legalization legislation. A key House committee recently approved a bill to end marijuana prohibition, and Senate leadership is finalizing a separate reform proposal.

In Mexico, a top Senator said this week that lawmakers could advance legislation to regulate marijuana in the coming weeks. The Supreme Court has already ruled that adults cannot be criminalized over possession or cultivation, but there’s currently no program in place to provide access.

New Bipartisan Marijuana Research Bill In Congress Would Let Scientists Study Dispensary Products

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

New Bipartisan Marijuana Research Bill In Congress Would Let Scientists Study Dispensary Products

Published

on

A bipartisan group of federal lawmakers introduced a bill on Thursday to remove barriers to conducting research on marijuana, including by allowing scientists to access cannabis from state-legal dispensaries.

The Medical Marijuana Research Act, filed by the unlikely duo of pro-legalization Rep. Earl Blumenauer (D-OR) and prohibitionist Rep. Andy Harris (R-MD), would streamline the process for researchers to apply and get approved to study cannabis and set clear deadlines on federal agencies to act on their applications.

“Congress is hopelessly behind the American people on cannabis, and the quality of our research shows why that is an urgent problem,” Blumenauer told Marijuana Moment. “Despite the fact that 99 percent of Americans live in a state that has legalized some form of cannabis, federal law is still hamstringing researchers’ ability to study the full range of health benefits offered by cannabis, and to learn more about the products readily available to consumers.”

“It’s outrageous that we are outsourcing leadership in that research to Israel, the United Kingdom, Canada, and others. It’s time to change the system,” he said.

Late last year, the House approved an identical version of the cannabis science legislation. Days later, the Senate passed a similar bill but nothing ended up getting to the president’s desk by the end of the last Congress. Earlier this year, a bipartisan group of senators refiled their marijuana research measure for the current 117th Congress.

Meanwhile, lawmakers are also advancing a separate strategy to open up dispensary cannabis to researchers. Large-scale infrastructure legislation that has passed both chambers in differing forms and which is pending final action contains provisions aimed at allowing researchers to study the actual marijuana that consumers are purchasing from state-legal businesses instead of having to use only government-grown cannabis.

The new bill filed this week by Blumenauer and Harris, along with six other original cosponsors, would also make it easier for scientists to modify their research protocols without having to seek federal approval.


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

It would additionally mandate that the Drug Enforcement Administration (DEA) license more growers and make it so there would be no limit on the number of additional entities that can be registered to cultivate marijuana for research purposes. It would also require the U.S. Department of Health and Human Services (HHS) to submit a report to Congress within five years after enactment to overview the results of federal cannabis studies and recommend whether they warrant marijuana’s rescheduling under federal law.

“The cannabis laws in this country are broken, including our laws that govern cannabis research,” Blumenauer said in remarks in the Congressional Record. “Because cannabis is a Schedule I substance, researchers must jump through hoops and comply with onerous requirements just to do basic research on the medical potential of the plant.”

The new legislation will “both streamline the often-duplicative licensure process for researchers seeking to conduct cannabis research and facilitate access to an increased supply of higher quality medical grade cannabis for research purposes,” he said, adding that expanded studies will help make sure “Americans have adequate access to potentially transformative medicines and treatments.”

For half a century, researchers have only been able to study marijuana grown at a single federally approved facility at the University of Mississippi, but they have complained that it is difficult to obtain the product and that it is of low quality. Indeed, one study showed that the government cannabis is more similar to hemp than to the marijuana that consumers actually use in the real world.

There’s been bipartisan agreement that DEA has inhibited cannabis research by being slow to follow through on approving additional marijuana manufacturers beyond the Mississippi operation, despite earlier pledges to do so.

In May, the agency finally said it was ready to begin licensing new cannabis cultivators. Last week, DEA proposed a large increase in the amount of marijuana—and psychedelics such as psilocybin, LSD, MDMA and mescaline—that it wants produced in the U.S. for research purposes next year.

Under the new House bill, the agency would be forced to start approving additional cultivation applications for study purposes within one year of the legislation’s enactment.

HHS and the attorney general would be required under the bill to create a process for marijuana manufacturers and distributors to supply researchers with cannabis from dispensaries. They would have one year after enactment to develop that procedure, and would have to start meeting to work on it within 60 days of the bill’s passage.

In general, the legislation would also establish a simplified registration process for researchers interested in studying cannabis, in part by reducing approval wait times, minimizing costly security requirements and eliminating additional layers of protocol review.

Read the full text of the new marijuana research bill below:

Click to access medical-marijuana-research-act-hr-5657-text.pdf

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment